Sinn BV, Loibl S, Hanusch CA, Zahm DM, et al. Immune-related gene expression predicts response to neoadjuvant chemotherapy but not additional benefit from PD-L1 inhibition in women with early triple-negative breast cancer. Clin Cancer Res 2021 Feb 16. pii: 1078-0432.CCR-20-3113.
PMID: 33593886